These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 26014226)
1. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Du M; Shi D; Yuan L; Li P; Chu H; Qin C; Yin C; Zhang Z; Wang M Sci Rep; 2015 May; 5():10437. PubMed ID: 26014226 [TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis. Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216 [TBL] [Abstract][Full Text] [Related]
3. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related]
4. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907 [TBL] [Abstract][Full Text] [Related]
5. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer. Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210 [TBL] [Abstract][Full Text] [Related]
6. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer. Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266 [TBL] [Abstract][Full Text] [Related]
7. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Fayyad-Kazan H; Bitar N; Najar M; Lewalle P; Fayyad-Kazan M; Badran R; Hamade E; Daher A; Hussein N; ElDirani R; Berri F; Vanhamme L; Burny A; Martiat P; Rouas R; Badran B J Transl Med; 2013 Feb; 11():31. PubMed ID: 23391324 [TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917 [TBL] [Abstract][Full Text] [Related]
9. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer. You W; Wang Y; Zheng J Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838 [TBL] [Abstract][Full Text] [Related]
10. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer. Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263 [TBL] [Abstract][Full Text] [Related]
15. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer. Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524 [TBL] [Abstract][Full Text] [Related]
16. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Chen Y; Chen J; Liu Y; Li S; Huang P Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771 [TBL] [Abstract][Full Text] [Related]
17. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
18. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
19. A plasma microRNA panel for early detection of colorectal cancer. Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911 [TBL] [Abstract][Full Text] [Related]
20. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer. Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]